Plenary Sessions and Speakers

Mesenchymal and Progenitor Stem Cells: Results from the Clinic and the Future of Living Drugs

  • Chair: Allan Dietz, PhD, Mayo Clinic
  • Speakers: 
    • Allan Dietz, PhD, Mayo Clinic
    • Gil Van Bokkelen, PhD, Athersys
    • Etienne Sokal, MD, PhD, Promethera, Universite Catholique de Louvain
Emerging Strategies in Regenerative
Medicine
  • Chair: William Murphy, PhD, UW-Madison
  • Speakers:
    • William Murphy, PhD, UW-Madison
    • Timothy Kamp, MD, PhD, UW-Madison
    • Mervin Yoder, MA, MD, Indiana University School of Medicine

iPSC and Pluripotent Stem Cells – True Replacement Cell Therapies

  • Chair: Robert Deans, PhD, BlueRock Therapeutics
  • Speakers: 
    • Dan Kaufman, MD, PhD, University of California San Diego
    • Stephanie Protze, PhD, University of Toronto
    • Robert Deans, PhD, BlueRock Therapeutic

Redirecting Immune Cells – T and NK Cells Aside from Canonical CARS
  • Chair: Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute
  • Speakers:
    • Denis-Claude Roy, MD, Hôpital Maisonneuve-Rosemont
    • Sumithira Vasu, MBBS, Ohio State University
    • Lisa Butterfield, PhD, PICI, UCSF

Concurrent Sessions and Speakers

Workshops

MSC therapy; Rationalism vs. Empiricism; how much must we know to test therapies in patients; a Live Debate

  • Moderator: Allan Dietz, PhD, Mayo Clinic, USA
  • Speakers:
    • Jacques Galipeau, MD, University of Wisconsin-Madison, USA
    • William Faubion, MD, Mayo Clinic, USA

Virus Specific T Cells – Meet the Experts

  • Chair: Lynn O’Donnell
  • Speakers:
    • Catherine Bollard, MBChB, MD, Children’s National Medical Center, USA
    • John Barrett, MD, George Washington University Hospital, USA
    • Michael Grimley, MD, Cincinnati Children’s Hospital Medical Center, USA

Engineering to Control Cell Environment during Expansion

  • Chair: Erika Trauzzi, Berkeley Lights Inc., USA
  • Speakers:
    • James Lim, PhD, Xcell Biosciences Inc., USA
    • Peter Beemiller, Berkeley Lights Inc., USA
    • Angelo Cardoso, MD, PhD, City of Hope, USA

CAR-T Racing: Amateurs & Rookies Looking to Contribute

  • Chair: Patrick Hanley, PhD, Children’s National Health System, USA
  • Speakers:
    • Lizette Caballero, BS, MT(ASCP), UCSF Blood and Marrow Transplant Lab, USA
    • Paul Eldridge, PhD, UNC Lineberger Comprehensive Cancer Center, USA
    • Hema Dave, MD, MPH, Children’s National Medical Center, USA

CAR-T Racing: The Pro Circuit + Future Prospects

  • Chair: Bruce Levine, PhD, University of Pennsylvania, USA
  • Speakers:
    • Rebecca Gardner, MD, Seattle Children’s Hospital, USA
    • Krishanu Saha, PhD, University of Wisconsin-Madison, USA
    • Saar Gill, MD, PhD, Perelman School of Medicine, University of Pennsylvania, USA

ISCT-NAVRMA Joint Session: Veterinary medicine in developing cell-based therapies and bioengineering approach for human clinical use

  • Co-Chairs: Daniel Weiss, MD, PhD, University of Vermont, USA and Tracey Webb, DVM, PhD, Colorado State University, USA
  • Speakers:
    • Andrew Hoffman, DVM, DVSc, DACVIM, University of Pennsylvania School of Veterinary Medicine, USA
    • Kyla Ortved, DVM, PhD, University of Pennsylvania School of Veterinary Medicine, USA
    • Aimee Colbath, DVM, Michigan State University, USA
    • Dori Borjesson, BA, DVM, MPVM, PhD, UC Davis School of Veterinary Medicine, USA

ISCT PTF Session: Regulatory Aspects of Unproven Cell Therapies in North America

  • Chair: Laertis Ikonomou, PhD, Boston University, USA
  • Speakers:
    • Peter Marks, MD, PhD, Center for Biologics Evaluation and Research, FDA, USA
    • Lynne Boxer, DVM, Office of New Animal Drug Evaluation, Center for Veterinary Medicine, FDA, USA
    • Ajay Kuriyan, MD, MS, Department of Ophthalmology, University of Rochester Medical Center, USA
    • Kristin Matthews, PhD, Rice University’s Baker Institute for Public Policy, USA

Gene Replacement Therapy Using Adult Stem Cells

  • Chair: Mitchell Cairo, MD, New York Medical College, USA
  • Speakers:
    • Mitchell Cairo, MD, New York Medical College, USA
    • Jeffrey Medin, PhD, Medical College of Wisconsin, USA
    • Paul Orchard, MD, University of Minnesota, USA

Optimizing Clinical Trials in Cellular Therapy

  • Chair: Denis-Claude Roy, MD, FRCPC, Hopital Maisonneuve-Rosemont, Canada
  • Speakers:
    • Lauralyn McIntyre, MD, MHSc, FRCPC, Ottawa Hospital Research Institute, Canada
    • Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Institute, USA
    • Steven Devine, MD, CIBMTR, USA

Regulatory Updates – What You Need to Know When Filing Novel IND’s

  • Chair: Olive Sturtevant, MHP, MT(ASCP)SBB, Dana-Farber CMCF, USA
  • Speakers:
    • Jessica Chery, FDA, USA
    • Amanda Mack, PhD, FUJIFILM Corporation, USA
    • Whitney Gladney, PhD, University of Pennsylvania Perelman School of Medicine, USA

Quality & Operations Track

Strategies for Instituting Materials Management Program for Cell and Gene Therapy Products

  • Chair: Aisha Khan, MS, MBA, University of Miami, USA
  • Speakers:
    • Robert Lindblad, MD, EMMES, USA
    • Yong Fan, MD, A2Z Reg Solutions, USA
    • Lynn O’Donnell, PhD, Ohio State University, James Cancer Hospital Columbus, USA

Synchronizing CMC Preparation for Commercial Approval with Regulatory Accelerators

  • Chair: Yong Fan, MD, A2Z Reg Solutions, USA
  • Speakers:
    • Mo Heidaran, PhD, PAREXEL, USA
    • Marianna Sabatino, MD, Arcellx, USA

Media Fills

  • Chair: Rosemarie Bell, B.App.Sc Micro/Biochem MASM, QIMR Berghofer Medical Research Institute/Q-Gen Cell Therapeutics, Australia
  • Speaker:
    • Adrian Gee, PhD, Baylor College of Medicine, USA
    • Aisha Khan, MS, MBA, University of Miami, USA

Managing Growth in the Lab

  • Chair: Lynn O’Donnell, PhD, Ohio State University, James Cancer Hospital Columbus, USA

Stability

  • Chair: Karl Stasko, BSc, MPH, Dana Farber Cancer Institute, USA
  • Speakers:
    • Rosemarie Bell, B.App.Sc Micro/Biochem MASM, QIMR Berghofer Medical Research Institute/Q-Gen Cell Therapeutics, Australia
    • Jackie Damen, PhD, Senior Scientific Advisor, Hematopoiesis, Canada
    • Karl Stasko, BSc, MPH, Dana Farber Cancer Institute, USA

Currently Clinical Development Regulatory Guidance – Context and Implications

  • Chair: Kurt Gunter, MD, Cell Medica Inc, USA
  • Speakers:
    • Peiman Hematti, MD, University of Wisconsin-Madison School of Medicine and Public Health, USA
    • Cynthia Molina, Triumvira, USA

ISCT-ASFA Joint Session: Current Concepts in Cell Collections: HPCs, CAR-T & Regulatory Oversight

  • Co-Chairs: Joseph Schwartz and Lizette Caballero
  • Speakers:
    • Donald Siegel, MD, PhD, Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, USA
    • Anand Padmanabhan, MD, PhD, Blood Center of Wisconsin, USA
    • Yvette Tanhehco, PhD, MD MS, Columbia University Irving Medical Center, USA

Real World Evidence

  • Chair: Jiwen Zhang, PhD, PassageBio, USA
  • Speakers:
    • Adnan Jaigirdar, MD, Medical Officer, Oncology Branch; Division of Clinical Evaluation, Pharmacology and Toxicology; OTAT, CBER, FDA, USA
    • Leanne Larson, MHA, Parexel International USA

Advanced Practice Professionals Track

Management of CRS toxicity or other reactions related to CAR therapy

  • Chair: Valkal Bhatt, PharmD, BCOP, BCPS, Memorial Sloan Kettering Cancer Center, USA
  • Speakers:
    • Christina Bachmeier, PharmD, BCOP, Moffitt Cancer Center, USA
    • Rebecca Gonzalez, PharmD, BCOP, Moffitt Cancer Center, USA
    • Marian Dam, DNP, APRN, Moffitt Cancer Center, USA

Responsibilities of the Investigator and the Lab in the investigation, communication and reporting of Adverse Events

  • Chair: Valkal Bhatt, PharmD, BCOP, BCPS, Memorial Sloan Kettering Cancer Center, USA
  • Speakers:
    • Julia Thebiay, IMPACT, Mayo Clinic Rochester, USA
    • Ashwani Khurana, PhD, Mayo Clinic Rochester, USA